新型口服抗凝药-话题@MedSci

#新型口服抗凝药#

27篇内容 | 1687人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1943158, encodeId=216419431589d, content=<a href='/topic/show?id=994f5820890' target=_blank style='color:#2F92EE;'>#新型口服抗凝药#</a>, objectTitle=新型口服抗凝药物在非瓣膜病心房颤动治疗的中国专家建议（讨论稿）, objectType=article, longId=33787, objectId=168e33e8724, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=168e33e8724, replyNumber=0, likeNumber=73, createdTime=2014-10-11, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=168e33e8724, moduleTitle=新型口服抗凝药物在非瓣膜病心房颤动治疗的中国专家建议（讨论稿）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=168e33e8724)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943161, encodeId=7b2f194316186, content=<a href='/topic/show?id=994f5820890' target=_blank style='color:#2F92EE;'>#新型口服抗凝药#</a>, objectTitle=《非瓣膜病心房颤动患者新型口服抗凝药的应用中国专家共识》发布, objectType=article, longId=46055, objectId=857f46055da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=857f46055da, replyNumber=0, likeNumber=81, createdTime=2015-11-29, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=857f46055da, moduleTitle=《非瓣膜病心房颤动患者新型口服抗凝药的应用中国专家共识》发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=857f46055da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943159, encodeId=4bef1943159ff, content=<a href='/topic/show?id=994f5820890' target=_blank style='color:#2F92EE;'>#新型口服抗凝药#</a>, objectTitle=武剑：新型口服抗凝药时代，从循证证据到指南, objectType=article, longId=38227, objectId=183a3822e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=183a3822e42, replyNumber=0, likeNumber=67, createdTime=2015-01-01, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=183a3822e42, moduleTitle=武剑：新型口服抗凝药时代，从循证证据到指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=183a3822e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943157, encodeId=e640194315ed0, content=<a href='/topic/show?id=994f5820890' target=_blank style='color:#2F92EE;'>#新型口服抗凝药#</a>, objectTitle=Eur Heart J：围术期新型口服抗凝药的应用策略, objectType=article, longId=29409, objectId=537229409eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=537229409eb, replyNumber=0, likeNumber=55, createdTime=2014-11-13, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=537229409eb, moduleTitle=Eur Heart J：围术期新型口服抗凝药的应用策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=537229409eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943156, encodeId=760c19431563b, content=<a href='/topic/show?id=994f5820890' target=_blank style='color:#2F92EE;'>#新型口服抗凝药#</a>, objectTitle=Thorax：新型口服抗凝药治疗肺栓塞具有更高的安全性, objectType=article, longId=18701, objectId=42cd18e014a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42cd18e014a, replyNumber=0, likeNumber=55, createdTime=2013-06-18, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42cd18e014a, moduleTitle=Thorax：新型口服抗凝药治疗肺栓塞具有更高的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42cd18e014a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943154, encodeId=6a301943154db, content=<a href='/topic/show?id=994f5820890' target=_blank style='color:#2F92EE;'>#新型口服抗凝药#</a>, objectTitle=JACC：新型口服抗凝药预防房颤患者卒中有差异, objectType=article, longId=8991, objectId=a04589918c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a04589918c, replyNumber=0, likeNumber=47, createdTime=2013-03-24, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a04589918c, moduleTitle=JACC：新型口服抗凝药预防房颤患者卒中有差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a04589918c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943153, encodeId=ee0119431532b, content=<a href='/topic/show?id=994f5820890' target=_blank style='color:#2F92EE;'>#新型口服抗凝药#</a>, objectTitle=马长生:新型口服抗凝药在房颤卒中预防中的进展, objectType=article, longId=6969, objectId=4382696927, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4382696927, replyNumber=0, likeNumber=66, createdTime=2013-03-21, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4382696927, moduleTitle=马长生:新型口服抗凝药在房颤卒中预防中的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4382696927)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943155, encodeId=45a119431551e, content=<a href='/topic/show?id=994f5820890' target=_blank style='color:#2F92EE;'>#新型口服抗凝药#</a>, objectTitle=AIM：新型口服抗凝药对ACS患者没有临床净获益, objectType=article, longId=10009, objectId=9cf81000995, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cf81000995, replyNumber=0, likeNumber=80, createdTime=2013-05-22, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cf81000995, moduleTitle=AIM：新型口服抗凝药对ACS患者没有临床净获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cf81000995)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943152, encodeId=1c1019431526b, content=<a href='/topic/show?id=994f5820890' target=_blank style='color:#2F92EE;'>#新型口服抗凝药#</a>, objectTitle=新型口服抗凝药在房颤和ACS中将上位, objectType=article, longId=5363, objectId=968f536391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=968f536391, replyNumber=0, likeNumber=81, createdTime=2013-02-13, rootId=0, userName=zhangmingxiang, userId=c6fc262, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=968f536391, moduleTitle=新型口服抗凝药在房颤和ACS中将上位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=968f536391)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

新型口服抗凝药

2020-05-29

zhangmingxiang (审核中...)

前往app查看评论内容

#新型口服抗凝药#

新型口服抗凝药物在非瓣膜病心房颤动治疗的中国专家建议（讨论稿）

2014-10-11

zhangmingxiang (审核中...)

前往app查看评论内容

#新型口服抗凝药#

《非瓣膜病心房颤动患者新型口服抗凝药的应用中国专家共识》发布

2015-11-29

zhangmingxiang (审核中...)

前往app查看评论内容

#新型口服抗凝药#

武剑：新型口服抗凝药时代，从循证证据到指南

2015-01-01

zhangmingxiang (审核中...)

前往app查看评论内容

#新型口服抗凝药#

Eur Heart J：围术期新型口服抗凝药的应用策略

2014-11-13

zhangmingxiang (审核中...)

前往app查看评论内容

#新型口服抗凝药#

Thorax：新型口服抗凝药治疗肺栓塞具有更高的安全性

2013-06-18

zhangmingxiang (审核中...)

前往app查看评论内容

#新型口服抗凝药#

JACC：新型口服抗凝药预防房颤患者卒中有差异

2013-03-24

zhangmingxiang (审核中...)

前往app查看评论内容

#新型口服抗凝药#

马长生:新型口服抗凝药在房颤卒中预防中的进展

2013-03-21

zhangmingxiang (审核中...)

前往app查看评论内容

#新型口服抗凝药#

AIM：新型口服抗凝药对ACS患者没有临床净获益

2013-05-22

zhangmingxiang (审核中...)

前往app查看评论内容

#新型口服抗凝药#

新型口服抗凝药在房颤和ACS中将上位

2013-02-13

科室
- - 订阅+
  - 更多科室
工具
服务